Related Experiment Video

Updated: Oct 18, 2026

Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations
05:04

Enhancing the Development and Growth of Infant Cerebral Palsy Rats Using Selective Spinal Manipulations

Published on: February 2, 2024

Prevention of cerebral palsy in glutaric aciduria type 1 by dietary management

A A Monavari1, E R Naughten

  • 1National Centre for Inherited Metabolic Disorders, The Children's Hospital, Temple Street, Dublin 1, Ireland.

Archives of Disease in Childhood
|January 12, 2000
PubMed

Insights

Early diagnosis and treatment of glutaric aciduria type 1 (GA1) significantly improve patient outcomes. Family screening identifies affected individuals early, preventing severe neurological damage and improving developmental trajectories compared to late diagnosis.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatric Neurology

Background:

  • Glutaric aciduria type 1 (GA1) is a rare inherited metabolic disorder.
  • It results from deficiency of the enzyme glutaryl-CoA dehydrogenase, leading to accumulation of toxic metabolites.
  • GA1 can cause severe neurological damage, including movement disorders and intellectual disability.

Purpose of the Study:

  • To retrospectively analyze the treatment effects and clinical outcomes in 12 patients with GA1.
  • To compare outcomes between patients diagnosed via family screening versus those diagnosed after symptomatic presentation.

Main Methods:

  • Retrospective study of 12 GA1 patients at the National Centre for Inherited Metabolic Disorders, Dublin.
  • Comparison of outcomes in two groups: 6 diagnosed by family screening and 6 diagnosed late after symptom onset.

Main Results:

  • Children diagnosed through family screening had better outcomes: 4 were developmentally normal, 1 had mild intellectual disability, and 1 died.
  • Late-diagnosed patients predominantly developed dyskinetic cerebral palsy (6/6), and 5 of them died.

Conclusions:

  • Early detection and intensive management of GA1 are crucial for altering its natural history.
  • Family screening facilitates early diagnosis, leading to significantly improved neurodevelopmental outcomes and reduced mortality in GA1 patients.
Abstract

More Related Videos

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes03:19

Modifying Levels of Maternal Dietary Folic Acid or Choline to Study the Impact of Deficiencies on Offspring Health Outcomes

Published on: June 28, 2024

Abdominal Massage to Improve Motor Dysfunction in Rats with Cerebral Palsy08:24

Abdominal Massage to Improve Motor Dysfunction in Rats with Cerebral Palsy

Published on: August 11, 2023

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment: